Latest Respiratory physiology Stories

Discovery Labs Initiates Research Projects with Leading Research Institutions and US Government Agencies to Assess KL(4) Surfactant Utility in Acute Lung Injury

2012-09-27 02:26:39

WARRINGTON, Pa., Sept. 27, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), today announced the initiation of four research projects designed to explore the use of its proprietary KL(4) surfactant technology for the prevention and treatment of acute lung injury (ALI). Discovery Labs believes that KL(4) surfactant may be an effective intervention for people at risk for, or with, ALI. The company is collaborating with leading research institutions in a series of...

New Health App For Smartphones Measures Lung Function

2012-09-24 15:02:04

Lee Rannals for redOrbit.com - Your Universe Online As part of an increasingly popular trend toward health-focused smartphone applications, a new iPhone app allows people to measure their lung function directly through their smartphones. Researchers at the University of Washington, UW Medicine and Seattle Children's Hospital developed the application to allow people to monitor their lung function at home or on the go by simply blowing into their phone. Typically, people who suffer...

Masimo Pronto-7® Wins GOLD "Stevie®" Award for Best New Health Product

2012-09-20 10:27:48

IRVINE, Calif., Sept. 20, 2012 /PRNewswire/ -- Masimo Corporation (NASDAQ: MASI) announced today that its Pronto-7(®) handheld noninvasive hemoglobin, arterial oxygen saturation (SpO2), pulse rate, and perfusion index spot-check testing device earned a 2012 GOLD Stevie(®) American Business Award for the Best New Product or Service in the Health & Pharmaceuticals category. (Photo: http://photos.prnewswire.com/prnh/20120109/LA31863) This marks the fourth industry award the...

PMD Healthcare, Maker of the Spiro PD Personal Spirometer, Conducts Free Educational Webinars for People with Respiratory Conditions

2012-09-18 23:02:29

Ongoing series of webinars featuring healthcare professionals and patients address the challenges faced by people with lung disease. PMD Healthcare manufactures Spiro PD, the world’s first truly personal spirometer. For more information, visit http://www.SpiroPD.com. Allentown, PA (PRWEB) September 18, 2012 PMD Healthcare is conducting a series of free webinars to help educate and empower people with lung diseases – asthma, chronic obstructive pulmonary disease (COPD), bronchitis,...

Newly-Published Study Compares SURFAXIN® with Animal-Derived Surfactants in Well-Established Model of RDS

2012-09-06 02:32:32

WARRINGTON, Pa., Sept. 6, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the publication of SURFAXIN(® )(lucinactant) preclinical data in Pediatric Research. Using a well-established preterm lamb model of respiratory distress syndrome (RDS), study investigators concluded that early intervention with SURFAXIN may mitigate progression of pulmonary...

Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149

2012-09-02 22:21:01

TOKYO, September 3, 2012 /PRNewswire/ -- - QVA149 demonstrated superior bronchodilation compared to indacaterol 150 mcg, glycopyrronium 50 mcg, salmeterol/fluticasone 50/500 mcg BID, OL tiotropium 18 mcg and placebo[1,2] - Seebri(R) Breezhaler(R) (glycopyrronium bromide) demonstrated rapid, sustained bronchodilation and reduced exacerbations similar to OL tiotropium 18 mcg in GLOW pooled data analysis[3,4]...

Discovery Labs Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant

2012-07-18 02:26:10

WARRINGTON, Pa., July 18, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) today announced it has received a patent issued by the United States Patent and Trademark Office (USPTO) entitled "Pulmonary Surfactant Formulations and Methods for Promoting Mucus Clearance." The claims of the patent (U.S. Patent Number 8,221,772) provide coverage for a method for promoting mucus clearance in a patient with a pulmonary condition characterized by excessive mucus secretion or...

New Study Affirms Masimo rainbow® Pulse CO-Oximetry(TM) Accuracy for Noninvasive Carboxyhemoglobin and Methemoglobin Measurements

2012-07-09 02:25:45

IRVINE, Calif., July 9, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today a new study in Respiratory Physiology & Neurobiology shows that noninvasive carboxyhemoglobin (SpCO®) and methemoglobin (SpMet®) measurements with Masimo rainbow® Pulse CO-Oximetry(TM) are accurate and conclude they can be used as an effective first screening test with emergency room patients suspected of suffering carbon monoxide (CO) poisoning.(1) CO poisoning is a major cause of morbidity and...

Masimo Signs Pronto-7(TM) Distribution Deal with PSS World Medical

2012-07-02 02:24:30

IRVINE, Calif., July 2, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that PSS World Medical, Inc., (NASDAQ: PSSI) a leading national distributor of medical supplies and equipment to office-based physicians, will distribute the new Pronto-7(TM) - a palm-sized handheld device designed for quick and easy noninvasive spot-checking of total hemoglobin (SpHb®), SpO2, pulse rate, and perfusion index. (Photo: http://photos.prnewswire.com/prnh/20110808/LA46231) Pronto-7...

Newly-Published Study Compares SURFAXIN LS(TM) and CUROSURF® in Well-Established Model of Respiratory Distress Syndrome

2012-05-09 02:24:03

WARRINGTON, Pa., May 9, 2012 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, reported that data from a preclinical study of SURFAXIN LS(TM) (lyophilized KL(4 )surfactant) was recently published in the May issue of Pediatric Research. The results of the study demonstrate that improvements in lung function following administration of SURFAXIN LS compares favorably to...